120 STAT. 2292
PUBLIC LAW 109–364—OCT. 17, 2006
(3) were within a structure or vehicle while it was struck by a depleted uranium munition; (4) climbed on or entered equipment or structures struck by a depleted uranium munition; or (5) were medical personnel who provided initial treatment to members of the Armed Forces described in paragraph (1), (2), (3), or (4). (c) REPORT.—Not later than one year after the date of the enactment of this Act, the Secretary of Defense shall submit to Congress a report on the results of the study described in subsection (a). SEC. 717. REPORT AND PLAN ON SERVICES TO MILITARY DEPENDENT CHILDREN WITH AUTISM.
(a) PLAN REQUIRED.—The Secretary of Defense shall, within 180 days after the date of the enactment of this Act, develop a plan to provide services to military dependent children with autism pursuant to the authority for an extended health care services program in subsections (d) and (e) of section 1079 of title 10, United States Code. Such plan shall include— (1) requirements for the education, training, and supervision of individuals providing services for military dependent children with autism; (2) standards for identifying and measuring the availability, distribution, and training of individuals of various levels of expertise to provide such services; and (3) procedures to ensure that such services are in addition to other publicly provided services to such children. (b) PARTICIPATION OF AFFECTED FAMILIES.—In developing the plan required under subsection (a), the Secretary shall ensure the involvement and participation of affected military families or their representatives. (c) REPORT REQUIRED.—Not later than 30 days after completion of the plan required under subsection (a), the Secretary shall submit to the Committees on Armed Services of the Senate and the House of Representatives a report on the plan. The report may include any additional information the Secretary considers relevant. SEC. 718. COMPTROLLER GENERAL STUDY ON DEPARTMENT OF DEFENSE PHARMACY BENEFITS PROGRAM.
(a) IN GENERAL.—The Comptroller General of the United States shall conduct a study of the Department of Defense pharmacy benefits program required by section 1074g of title 10, United States Code. (b) ELEMENTS.—The study required by subsection (a) shall include an examination of the following: (1) The cost of the Department of Defense pharmacy benefits program since the inception of the program. (2) The relative costs of various options under the program. (3) The copayment structure under the program. (4) The effectiveness of the rebate system under the program as a way of passing on discounts received by the Federal Government in the purchase of pharmaceutical agents. (5) The uniform formulary under the program, including the success of the formulary in achieving savings anticipated through use of the formulary.
VerDate 14-DEC-2004
13:05 Jul 12, 2007
Jkt 059194
PO 00002
Frm 01036
Fmt 6580
Sfmt 6581
E:\PUBLAW\PUBL002.109
APPS06
PsN: PUBL002
�
